In-vivo measurement of tau depositions in anti-IgLON5 disease with 18F-PI2620-PET
Objective: The aim of the study was to examine the potential of the second-generation tau-PET tracer 18F-PI2620 to detect tau deposition in anti-IgLON5 disease. Background:…Altered Brain Connectivity in Hyperkinetic Movement Disorders: Systematic Review of Resting-State fMRI Studies
Objective: Providing a comprehensive literature review of resting-state brain connectivity alterations using resting-state fMRI (rs-fMRI) in hyperkinetic movement disorders (HMD). We additionally discuss alterations from…Late Onset Hemichorea Of Vascular Origin In A Middle Aged Female With Recent Onset Diabetes
Objective: Late onset hemichorea in a diabetic patient could be either due to a vascular cause or Chorea Hyperglycemia Basal Ganglia Syndrome. The distinction between…Designing a multi-arm multi-stage trial for Parkinson’s
Objective: The Edmond J Safra ACT-PD initiative (EJS ACT-PD) is developing the first multi-arm multi-stage (MAMS) platform trial for potential disease modifying approaches for Parkinson’s…Reducing corticospinal excitability with transcranial static magnetic field stimulation
Objective: To investigate the potential of transcranial static magnetic field stimulation (tSMS) for reducing corticospinal excitability when delivered to the primary motor cortex (M1) or…Assessment of microstructural changes associated with levodopa-induced dyskinesia in hemiparkinsonian rodents
Objective: To assess white matter (WM) microstructural integrity changes in pre-clinical models of Parkinson’s disease (PD) with levodopa-induced dyskinesia (LID). Background: PD is a neurodegenerative…Reduced Risk of Mortality and Antipsychotics in Parkinson’s Disease-Related Psychosis: Pimavanserin vs Off-Label Antipsychotics
Objective: Summarize the available data for the mortality risk associated with Parkinson’s disease (PD) psychosis (PDP) and pimavanserin. Background: PDP is associated with increased mortality…A case with clinical features of alpha-synuclein- and tauopathy: Genetic and histopathological workup.
Objective: Here, we present a clinical case that mimicked the coincidence of idiopathic Parkinson’s disease (PD) and tauopathy. Background: Mutation in leucine-rich-repeat-kinase 2 (LRRK2) gene…Analyzing gait videos to identify and evaluate spinocerebellar ataxia types 1 and 3
Objective: To analyze videos of gait to: 1) identify spinocerebellar ataxia types 1 and 3, and 2) predict scores on the gait task section of…Cognitive profiles at presentation and subsequent cognitive decline in PD-MCI.
Objective: To determine cognitive profiles in a Parkinson‘s Disease-Mild Cognitive Impairment (PD-MCI) cohort, and study the relationship between baseline cognitive phenotype and subsequent cognitive decline.…
- « Previous Page
- 1
- …
- 570
- 571
- 572
- 573
- 574
- …
- 1734
- Next Page »